GC
NDRM

GMT Capital’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

GMT Capital’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-34,938
Closed -$646K – 159
2016
Q3 		$646K Sell
34,938
-444,553
-93% -$7.71M 0.01% 122
2016
Q2 		$7.79M Sell
479,491
-184,458
-28% -$3.11M 0.19% 80
2016
Q1 		$9.38M Sell
663,949
-238,900
-26% -$3.23M 0.23% 69
2015
Q4 		$15.4M Buy
902,849
+336,200
+59% +$6.55M 0.4% 55
2015
Q3 		$13.1M Buy
+566,649
New +$11.6M 0.33% 68

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GMT Capital's NDRM Position: Q4 2016 in Review

GMT Capital sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2016, closing a stake of 34,938 shares — an estimated $646K sold.

GMT Capital first reported a position in NDRM in Q3 2015 and held it in 5 quarters. The position peaked at $15.4M in Q4 2015. 56 funds tracked by Wall St. Rank hold NDRM as of Q4 2016.

  • GMT Capital reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2016 after selling out during the quarter.
  • GMT Capital sold 34,938 NeuroDerm Ltd. Ordinary Shares shares in Q4 2016, an estimated $646K.
  • GMT Capital first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 5 quarters.
  • GMT Capital's NeuroDerm Ltd. Ordinary Shares position peaked at $15.4M in Q4 2015.
  • 56 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2016.

Based on GMT Capital's 13F filing for Q4 2016, filed 9 Feb 2017.